- Home
- HAWK vs INVA Comparison
HAWK vs INVA Comparison
Compare HAWK & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HAWK | INVA |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2026 | 2000 |
Fundamental Metrics
Financial Performance| Metric | HAWK | INVA |
|---|---|---|
| Price | $14.63 | $20.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | $32.56 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 1.2M | 733.2K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $217,217,000.00 |
| Revenue This Year | $84.87 | $9.72 |
| Revenue Next Year | $24.92 | $8.58 |
| P/E Ratio | ★ N/A | $16.88 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $15.21 | $16.52 |
| 52 Week High | $25.71 | $25.15 |
Technical Indicators
Market Signals| Indicator | HAWK | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 28.61 | 50.35 |
| Support Level | N/A | $20.39 |
| Resistance Level | $17.42 | $21.73 |
| Average True Range (ATR) | 0.68 | 0.47 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 2.26 | 66.39 |
Price Performance
Historical ComparisonAbout HAWK HawkEye 360 Inc. Common Stock
Hawkeye 360 Inc operates in the signals intelligence (SIGINT) and defense technology sector. It provides end-to-end signals intelligence solutions integrated into national security systems for the United States and allied customers. Its offerings include radio frequency data and related insights to support defense operations. The company is involved across the value chain, including satellite design and manufacturing, data collection, and data processing and analysis. It generates revenue prominently from fixed price contract arrangements for RF signal mapping products that are used to analyze and track radio waves.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.